Boaz Kurtis, MD

Vice President, Molecular Pathology at Interpace Biosciences

Boaz Kurtis, MD has a diverse work experience in the field of medicine and diagnostics. Boaz is currently serving as the Chief Executive Officer and Founder of Intersect Diagnostics, Inc., a translational biomarker research and development laboratory that specializes in single-cell, high-parameter spatial discovery technologies. Their role involves leading the company's efforts in advancing the development of precision therapeutics in collaboration with biopharmaceutical and biotech companies.

Prior to this, they worked as the Vice President of Molecular Pathology at Interpace Biosciences, where they were responsible for overseeing all molecular diagnostic programs and initiatives. Boaz collaborated with biopharma/biotech industry and physician clients to select and interpret appropriate molecular and immunohistochemical diagnostic assays.

Dr. Kurtis also served as the Laboratory & Medical Director and Staff Pathologist at Cancer Genetics, Inc. During their tenure, they executed diagnostic projects and delivered clinical molecular diagnostic results for patient care. Boaz specialized in high-complexity next-generation sequencing (NGS) and played a significant role in optimizing and validating assays for biomarker discovery and clinical diagnostics.

Furthermore, they gained valuable experience during their time at Columbia University Medical Center as a Molecular Genetic Pathology Fellow in the Laboratory for Personalized Genomic Medicine. In this role, they analyzed and interpreted molecular genetic data for clinical assays in various fields, including oncology, medical genetics, and infectious disease.

Earlier in their career, Dr. Kurtis served as the Chief Resident and Resident in the Department of Pathology and Laboratory Medicine at Westchester Medical Center. Boaz also worked as a Clinical Account Specialist at Biosense Webster, Inc., a Johnson & Johnson company, and as a Clinical Research Fellow in the Department of Dermatology at Northwestern University, Feinberg School of Medicine.

Dr. Kurtis completed their residency as a Resident in the Department of Pathology at Lenox Hill Hospital and their medical internship at St. Luke's-Roosevelt Hospital. Boaz began their research career as a Research Fellow in the Department of Dermatology at UT Southwestern Medical Center.

Throughout their career, Dr. Kurtis has demonstrated expertise in various molecular diagnostic techniques, including next-generation sequencing, real-time PCR, Sanger sequencing/capillary electrophoresis, FISH, and SNP oligonucleotide microarrays. Boaz has a strong focus on genomic data analysis, interpretation, and reporting for clinical genetic disorders and oncology.

Boaz Kurtis, MD holds a Bachelor of Arts degree in History from the University of Maryland. Additionally, they have earned a Doctor of Medicine (M.D.) degree from Tel Aviv University. However, specific details such as the start and end years for each educational institution are not mentioned in the provided information.

Links

Timeline

  • Vice President, Molecular Pathology

    October, 2018 - present

View in org chart